Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Clinical and Experimental Medicine
|
September 11, 2024
Identification of PFKFB3 as a key factor in the development of colorectal cancer and immunotherapy resistance
Si Lu, Rongjie Zhao, Yicheng Han, et al.
Journal of Cellular and Molecular Medicine
|
July 4, 2023
A negative feedback loop between KLF9 and the EMT program dictates metastasis of hepatocellular carcinoma
Tao Wang, Limin Feng, Zhong Shi, et al.
Cancer Letters
|
March 7, 2020
EM2D9, A monoclonal antibody against integrin α5β1, has potent antitumor activity on endometrial cancer in vitro and in vivo
Yinyan Xu, Yi Li, Jiahui Pan, et al.
Science Advances
|
January 10, 2025
Noncanonical UPR factor CREB3L2 drives immune evasion of triple-negative breast cancer through Hedgehog pathway modulation in T cells
Zi-Jian Cao, Jia You, Yu-Meng Fan, et al.
Cancer Medicine
|
March 26, 2019
Hope and challenge: Precision medicine in bladder cancer
Hongwei Su, Haitao Jiang, Tao Tao, et al.
Acta Pharmaceutica (Zagreb, Croatia)
|
March 30, 2024
Medicarpin suppresses lung cancer cell growth <i>in vitro</i> and <i>in vivo</i> by inducing cell apoptosis
Zongyi Shen, Liqi Yin, Manxia Chang, et al.
Chemical Biology & Drug Design
|
September 13, 2022
Glabridin inhibits urothelial bladder carcinoma cell growth in vitro and in vivo by inducing cell apoptosis and cell cycle arrest
Zhao Yang, Ying Bi, Wenkai Xu, et al.
Acta Pharmaceutica (Zagreb, Croatia)
|
June 12, 2023
Medicarpin induces G1 arrest and mitochondria-mediated intrinsic apoptotic pathway in bladder cancer cells
Yuan Chen, Liqi Yin, Mingxuan Hao, et al.
Cancer Science
|
January 5, 2023
Association of KMT2C/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer
Ruiqi Liu, Yanling Niu, Chao Liu, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Clinical and Experimental Medicine
|
September 11, 2024
Identification of PFKFB3 as a key factor in the development of colorectal cancer and immunotherapy resistance
Si Lu, Rongjie Zhao, Yicheng Han, et al.
Journal of Cellular and Molecular Medicine
|
July 4, 2023
A negative feedback loop between KLF9 and the EMT program dictates metastasis of hepatocellular carcinoma
Tao Wang, Limin Feng, Zhong Shi, et al.
Cancer Letters
|
March 7, 2020
EM2D9, A monoclonal antibody against integrin α5β1, has potent antitumor activity on endometrial cancer in vitro and in vivo
Yinyan Xu, Yi Li, Jiahui Pan, et al.
Science Advances
|
January 10, 2025
Noncanonical UPR factor CREB3L2 drives immune evasion of triple-negative breast cancer through Hedgehog pathway modulation in T cells
Zi-Jian Cao, Jia You, Yu-Meng Fan, et al.
Cancer Medicine
|
March 26, 2019
Hope and challenge: Precision medicine in bladder cancer
Hongwei Su, Haitao Jiang, Tao Tao, et al.
Acta Pharmaceutica (Zagreb, Croatia)
|
March 30, 2024
Medicarpin suppresses lung cancer cell growth <i>in vitro</i> and <i>in vivo</i> by inducing cell apoptosis
Zongyi Shen, Liqi Yin, Manxia Chang, et al.
Chemical Biology & Drug Design
|
September 13, 2022
Glabridin inhibits urothelial bladder carcinoma cell growth in vitro and in vivo by inducing cell apoptosis and cell cycle arrest
Zhao Yang, Ying Bi, Wenkai Xu, et al.
Acta Pharmaceutica (Zagreb, Croatia)
|
June 12, 2023
Medicarpin induces G1 arrest and mitochondria-mediated intrinsic apoptotic pathway in bladder cancer cells
Yuan Chen, Liqi Yin, Mingxuan Hao, et al.
Cancer Science
|
January 5, 2023
Association of KMT2C/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer
Ruiqi Liu, Yanling Niu, Chao Liu, et al.
Page
of 3